Deferred Revenue
Idexx Laboratories Deferred Revenue increased by 3.0% to $36.33M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.8%, from $35.00M to $36.33M. Over 5 years (FY 2020 to FY 2025), Deferred Revenue shows a downward trend with a -3.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase suggests strong sales of subscription-based services or bundled offerings, providing a predictable pipeline for future revenue recognition.
Detailed definition
Represents cash payments received from customers in advance of the company fulfilling its performance obligations, speci...
Peer comparison
High-growth software and services companies typically maintain larger deferred revenue balances relative to pure hardware manufacturers.
deferred_revenue_currentHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $41.13M | $41.13M | $40.03M | $40.91M | $40.78M | $40.81M | $37.94M | $37.84M | $37.78M | $37.28M | $37.20M | $38.19M | $38.00M | $38.43M | $33.80M | $35.00M | $36.32M | $35.69M | $35.26M | $36.33M |
| QoQ Change | — | -0.0% | -2.7% | +2.2% | -0.3% | +0.1% | -7.0% | -0.3% | -0.2% | -1.3% | -0.2% | +2.7% | -0.5% | +1.1% | -12.1% | +3.6% | +3.8% | -1.7% | -1.2% | +3.0% |
| YoY Change | — | — | — | — | -0.9% | -0.8% | -5.2% | -7.5% | -7.3% | -8.6% | -2.0% | +0.9% | +0.6% | +3.1% | -9.1% | -8.4% | -4.4% | -7.1% | +4.3% | +3.8% |
Deferred Revenue at Other Companies
Frequently Asked Questions
- What is Idexx Laboratories's deferred revenue?
- Idexx Laboratories (IDXX) reported deferred revenue of $36.33M in Q1 2026.
- How has Idexx Laboratories's deferred revenue changed year-over-year?
- Idexx Laboratories's deferred revenue increased by 3.8% year-over-year, from $35.00M to $36.33M.
- What is the long-term trend for Idexx Laboratories's deferred revenue?
- Over 5 years (2020 to 2025), Idexx Laboratories's deferred revenue has grown at a -3.7% compound annual growth rate (CAGR), from $42.57M to $35.26M.
- What does deferred revenue mean?
- Money collected from customers for products or services that haven't been delivered yet but will be within a year.